1-octadecanoyl-2-[(11Z)-octadecenoyl]-sn-glycerophosphochlonine

Metabolite details

Identifier

AEAMHDRXCYEOCU-HTDYWKJCSA-N

InChI Key

AEAMHDRXCYEOCU-HTDYWKJCSA-N

IUPAC name

(2R)-3-(octadecanoyloxy)-2-{[(11Z)-octadec-11-enoyl]oxy}propyl 2-(trimethylazaniumyl)ethyl phosphate

Preferred name

1-octadecanoyl-2-[(11Z)-octadecenoyl]-sn-glycerophosphochlonine

INN name

—

Synonym

PC(18:0/18:1)

ChEBI

CHEBI:86109

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Novel Potential Diagnostic Serum Biomarkers of Metabolomics in Osteoarticular Tuberculosis Patients: A Preliminary Study
• Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Normal_control_no_tumor_vs_FH_deficient_RCC
• Control_12h_vs_Toxocara canis_12h
• Healthy_Control_vs_Osteoarticular_Tuberculosis
• Control_Female_vs_Restricted_Female
• Control_Female_vs_Restricted_Female
• BSA_Control_vs_AA